Quantinno Capital Management LP Acquires New Shares in iShares Biotechnology ETF (NASDAQ:IBB)

Quantinno Capital Management LP bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 1,679 shares of the financial services provider’s stock, valued at approximately $244,000.

A number of other hedge funds also recently added to or reduced their stakes in IBB. BNP Paribas Financial Markets grew its holdings in iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after buying an additional 538,899 shares in the last quarter. Commerce Bank grew its stake in shares of iShares Biotechnology ETF by 1.8% in the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock worth $108,234,000 after purchasing an additional 12,921 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after purchasing an additional 164,000 shares in the last quarter. Main Management ETF Advisors LLC raised its stake in shares of iShares Biotechnology ETF by 2.6% during the second quarter. Main Management ETF Advisors LLC now owns 578,835 shares of the financial services provider’s stock valued at $79,451,000 after purchasing an additional 14,535 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. lifted its holdings in iShares Biotechnology ETF by 24.6% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock worth $29,792,000 after purchasing an additional 42,822 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $137.25 on Tuesday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The company’s 50-day moving average price is $141.74 and its two-hundred day moving average price is $142.40.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.